Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

G. William Rebeck

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Physiology

Genotype

Living Beings

Mice

Anatomy

Genes & Molecular Sequences

Alleles

Phenomena

Western Blotting

Procedures

Immunohistochemistry

Concepts & Ideas

Age of Onset

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
62
Hyman, Bradley
16
Greenberg, Steven
16
Hoe, Hyang-Sook
14
Strickland, Dudley
8
Growdon, John
8
Irizarry, Michael
8
Burns, Mark
7
Matsuoka, Yasuji
7
Gomez-Isla, Teresa
7
Tanzi, Rudolph
6
Pocivavsek, Ana
4
Nitsch, Roger
4
Cho, Hyun Soon
4
Clatworthy, AE
4
Deng, Amy

Sign-in to see all Coauthors

Publications

TOP 3
Pocivavsek Ana; Rebeck G William
Inhibition of c-Jun N-terminal kinase increases apoE expression in vitro and in vivo.
Pocivavsek Ana; Mikhailenko Irina; Strickland Dudley K; Rebeck G William
Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun N-terminal kinase activation.
Burns Mark P; Zhang Lihua; Rebeck G William; Querfurth Henry W; Moussa Charbel E-H
Parkin promotes intracellular Abeta1-42 clearance.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of G. William Rebeck (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Pocivavsek Ana; Rebeck G William
Inhibition of c-Jun N-terminal kinase increases apoE expression in vitro and in vivo.
Biochemical and biophysical research communications 2009;387(3):516-20.
2009: Pocivavsek Ana; Mikhailenko Irina; Strickland Dudley K; Rebeck G William
Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun N-terminal kinase activation.
Journal of neuroimmunology 2009;214(1-2):25-32.
2009: Burns Mark P; Zhang Lihua; Rebeck G William; Querfurth Henry W; Moussa Charbel E-H
Parkin promotes intracellular Abeta1-42 clearance.
Human molecular genetics 2009;18(17):3206-16.
2009: Tractenberg Rochelle E; Aisen Paul S; Hancock Gregory R; Rebeck G William
No cross-sectional influence of APOE epsilon4 dose on clinical tests in Alzheimer's disease.
Neurobiology of aging 2009;30(8):1327-8.
2009: Hoe Hyang-Sook; Lee Kea Joo; Carney Rosalind S E; Lee Jiyeon; Markova Alexandra; Lee Ji-Yun; Howell Brian W; Hyman Bradley T; Pak Daniel T S; Bu Guojun; Rebeck G William
Interaction of reelin with amyloid precursor protein promotes neurite outgrowth.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009;29(23):7459-73.
2009: Loane David J; Pocivavsek Ana; Moussa Charbel E-H; Thompson Rachel; Matsuoka Yasuji; Faden Alan I; Rebeck G William; Burns Mark P
Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury.
Nature medicine 2009;15(4):377-9.
2009: Hoe Hyang-Sook; Fu Zhanyan; Makarova Alexandra; Lee Ji-Yun; Lu Congyi; Feng Li; Pajoohesh-Ganji Ahdeah; Matsuoka Yasuji; Hyman Bradley T; Ehlers Michael D; Vicini Stefano; Pak Daniel T S; Rebeck G William
The effects of amyloid precursor protein on postsynaptic composition and activity.
The Journal of biological chemistry 2009;284(13):8495-506.
2009: Pocivavsek Ana; Burns Mark P; Rebeck G William
Low-density lipoprotein receptors regulate microglial inflammation through c-Jun N-terminal kinase.
Glia 2009;57(4):444-53.
2009: Hirata-Fukae Chiho; Li Hui-Fang; Ma Li; Hoe Hyang-Sook; Rebeck G William; Aisen Paul S; Matsuoka Yasuji
Levels of soluble and insoluble tau reflect overall status of tau phosphorylation in vivo.
Neuroscience letters 2009;450(1):51-5.
2009: Rebeck G William
Nontraditional signaling mechanisms of lipoprotein receptors.
Science signaling 2009;2(68):pe28.
2008: Zhao Xu; Rebeck G William; Hoe Hyang-Sook; Andrews Peter M
Tarenflurbil protection from cytotoxicity is associated with an upregulation of neurotrophins.
Journal of Alzheimer's disease : JAD 2008;15(3):397-407.
2008: Cartagena Casandra M; Ahmed Farid; Burns Mark P; Pajoohesh-Ganji Ahdeah; Pak Daniel T; Faden Alan I; Rebeck G William
Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain.
Journal of neurotrauma 2008;25(9):1087-98.
2008: Hoe Hyang-Sook; Rebeck George William
Functional interactions of APP with the apoE receptor family.
Journal of neurochemistry 2008;106(6):2263-71.
2008: Hirata-Fukae Chiho; Li Hui-Fang; Hoe Hyang-Sook; Gray Audrey J; Minami S Sakura; Hamada Katsuyoshi; Niikura Takako; Hua Fang; Tsukagoshi-Nagai Hiroe; Horikoshi-Sakuraba Yuko; Mughal Mohamed; Rebeck G William; LaFerla Frank M; Mattson Mark P; Iwata Nobuhisa; Saido Takaomi C; Klein William L; Duff Karen E; Aisen Paul S; Matsuoka Yasuji
Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.
Brain research 2008;1216():92-103.
2008: Hoe Hyang-Sook; Minami S Sakura; Makarova Alexandra; Lee Jiyeon; Hyman Bradley T; Matsuoka Yasuji; Rebeck G William
Fyn modulation of Dab1 effects on amyloid precursor protein and ApoE receptor 2 processing.
The Journal of biological chemistry 2008;283(10):6288-99.
2008: Hoe Hyang-Sook; Rebeck G William
Regulated proteolysis of APP and ApoE receptors.
Molecular neurobiology 2008;37(1):64-72.
2007: Hoe Hyang-Sook; Cooper Matthew J; Burns Mark P; Lewis Patrick A; van der Brug Marcel; Chakraborty Geetanjali; Cartagena Casandra M; Pak Daniel T S; Cookson Mark R; Rebeck G William
The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(40):10895-905.
2007: Eckert Gunter P; Vardanian Lilit; Rebeck G William; Burns Mark P
Regulation of central nervous system cholesterol homeostasis by the liver X receptor agonist TO-901317.
Neuroscience letters 2007;423(1):47-52.
2007: Czech Christian; Burns Mark P; Vardanian Lilit; Augustin Angelique; Jacobsen Helmut; Baumann Karlheinz; Rebeck G William
Cholesterol independent effect of LXR agonist TO-901317 on gamma-secretase.
Journal of neurochemistry 2007;101(4):929-36.
2006: Hoe Hyang-Sook; Tran Tracy S; Matsuoka Yasuji; Howell Brian W; Rebeck G William
DAB1 and Reelin effects on amyloid precursor protein and ApoE receptor 2 trafficking and processing.
The Journal of biological chemistry 2006;281(46):35176-85.
2006: Hoe Hyang-Sook; Pocivavsek Ana; Dai Haining; Chakraborty Geetanjali; Harris D Christopher; Rebeck G William
Effects of apoE on neuronal signaling and APP processing in rodent brain.
Brain research 2006;1112(1):70-9.
2006: Burns Mark P; Vardanian Lilit; Pajoohesh-Ganji Ahdeah; Wang Lili; Cooper Matthew; Harris Donnie C; Duff Karen; Rebeck G William
The effects of ABCA1 on cholesterol efflux and Abeta levels in vitro and in vivo.
Journal of neurochemistry 2006;98(3):792-800.
2006: Hoe Hyang-Sook; Magill Laura Ann; Guenette Suzanne; Fu Zhanyan; Vicini Stefano; Rebeck G William
FE65 interaction with the ApoE receptor ApoEr2.
The Journal of biological chemistry 2006;281(34):24521-30.
2006: Hoe Hyang-Sook; Pocivavsek Ana; Chakraborty Geetanjali; Fu Zhanyan; Vicini Stefano; Ehlers Michael D; Rebeck G William
Apolipoprotein E receptor 2 interactions with the N-methyl-D-aspartate receptor.
The Journal of biological chemistry 2006;281(6):3425-31.
2006: Robbins Elissa M; Betensky Rebecca A; Domnitz Sarah B; Purcell Susan M; Garcia-Alloza Monica; Greenberg Charles; Rebeck G William; Hyman Bradley T; Greenberg Steven M; Frosch Matthew P; Bacskai Brian J
Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(2):365-71.
2006: Hoe Hyang-Sook; Freeman Jacob; Rebeck G William
Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons.
Molecular neurodegeneration 2006;1():18.
2006: Rebeck G William; LaDu Mary Jo; Estus Steven; Bu Guojun; Weeber Edwin J
The generation and function of soluble apoE receptors in the CNS.
Molecular neurodegeneration 2006;1():15.
2005: Hoe Hyang-Sook; Wessner David; Beffert Uwe; Becker Amanda G; Matsuoka Yasuji; Rebeck G William
F-spondin interaction with the apolipoprotein E receptor ApoEr2 affects processing of amyloid precursor protein.
Molecular and cellular biology 2005;25(21):9259-68.
2005: Domnitz Sarah B; Robbins Elissa M; Hoang Alex W; Garcia-Alloza Monica; Hyman Bradley T; Rebeck G William; Greenberg Steven M; Bacskai Brian J; Frosch Matthew P
Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease.
Journal of neuropathology and experimental neurology 2005;64(7):588-94.
2005: Hoe Hyang-Sook; Rebeck G William
Regulation of ApoE receptor proteolysis by ligand binding.
Brain research. Molecular brain research 2005;137(1-2):31-9.
2005: Hoe Hyang-Sook; Harris D Christopher; Rebeck G William
Multiple pathways of apolipoprotein E signaling in primary neurons.
Journal of neurochemistry 2005;93(1):145-55.
2005: Martin-Rehrmann M D; Hoe H-S; Capuani E M; Rebeck G W
Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer's disease brain.
Neurotoxicity research 2005;7(3):231-42.
2004: Ingelsson Martin; Jesneck Jennifer; Irizarry Michael C; Hyman Bradley T; Rebeck G William
Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease.
Neuroscience letters 2004;367(2):228-31.
2004: Irizarry Michael C; Deng Amy; Lleo Alberto; Berezovska Oksana; Von Arnim Christine A F; Martin-Rehrmann Matthew; Manelli Arlene; LaDu Mary Jo; Hyman Bradley T; Rebeck G William
Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein.
Journal of neurochemistry 2004;90(5):1132-43.
2004: Qiu Zhihua; Hyman Bradley T; Rebeck G William
Apolipoprotein E receptors mediate neurite outgrowth through activation of p44/42 mitogen-activated protein kinase in primary neurons.
The Journal of biological chemistry 2004;279(33):34948-56.
2004: Eng Jessica A; Frosch Matthew P; Choi Kyungchan; Rebeck G William; Greenberg Steven M
Clinical manifestations of cerebral amyloid angiopathy-related inflammation.
Annals of neurology 2004;55(2):250-6.
2004: Rebeck G William
Cholesterol efflux as a critical component of Alzheimer's disease pathogenesis.
Journal of molecular neuroscience : MN 2004;23(3):219-24.
2003: Wang Xiaoying; Lee Sun-Ryung; Arai Ken; Lee Seong-Ryong; Tsuji Kiyoshi; Rebeck G William; Lo Eng H
Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.
Nature medicine 2003;9(10):1313-7.
2003: Fukumoto Hiroaki; Ingelsson Martin; Gårevik Nina; Wahlund Lars Olof; Nukina Nobuyuki; Yaguchi Yoshio; Shibata Masao; Hyman Bradley T; Rebeck G William; Irizarry Michael C
APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
Experimental neurology 2003;183(1):249-53.
2003: Greenberg S M; Shin Y; Grabowski T J; Cooper G E; Rebeck G W; Iglesias S; Chapon F; Tournier-Lasserve E; Baron J-C
Hemorrhagic stroke associated with the Iowa amyloid precursor protein mutation.
Neurology 2003;60(6):1020-2.
2003: Shin Youngah; Cho Hyun Soon; Fukumoto Hiroaki; Shimizu Takahiko; Shirasawa Takuji; Greenberg Steven M; Rebeck G William
Abeta species, including IsoAsp23 Abeta, in Iowa-type familial cerebral amyloid angiopathy.
Acta neuropathologica 2003;105(3):252-8.
2003: Qiu Z; Crutcher K A; Hyman B T; Rebeck G W
ApoE isoforms affect neuronal N-methyl-D-aspartate calcium responses and toxicity via receptor-mediated processes.
Neuroscience 2003;122(2):291-303.
2002: Fukumoto Hiroaki; Deng Amy; Irizarry Michael C; Fitzgerald Michael L; Rebeck G William
Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levels.
The Journal of biological chemistry 2002;277(50):48508-13.
2002: Shin Youngah; Cho Hyun Soon; Rebeck G William; Greenberg Steven M
Vascular changes in Iowa-type hereditary cerebral amyloid angiopathy.
Annals of the New York Academy of Sciences 2002;977():245-51.
2002: Guénette Suzanne Y; Chang Yang; Hyman Bradley T; Tanzi Rudolph E; Rebeck G William
Low-density lipoprotein receptor-related protein levels and endocytic function are reduced by overexpression of the FE65 adaptor protein, FE65L1.
Journal of neurochemistry 2002;82(4):755-62.
2002: Martin-Rehrmann Matthew D; Cho Hyun Soon; Rebeck G William
Lack of association of two lipoprotein lipase polymorphisms with Alzheimer's disease.
Neuroscience letters 2002;328(2):109-12.
2002: Arélin Katrin; Kinoshita Ayae; Whelan Christa M; Irizarry Michael C; Rebeck G William; Strickland Dudley K; Hyman Bradley T
LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes.
Brain research. Molecular brain research 2002;104(1):38-46.
2002: Rebeck G William; Kindy Mark; LaDu Mary Jo
Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3.
Journal of Alzheimer's disease : JAD 2002;4(3):145-54.
2002: Qiu Zhihua; Strickland Dudley K; Hyman Bradley T; Rebeck G William
alpha 2-Macroglobulin exposure reduces calcium responses to N-methyl-D-aspartate via low density lipoprotein receptor-related protein in cultured hippocampal neurons.
The Journal of biological chemistry 2002;277(17):14458-66.
2001: Cataldo A; Rebeck G W; Ghetri B; Hulette C; Lippa C; Van Broeckhoven C; van Duijn C; Cras P; Bogdanovic N; Bird T; Peterhoff C; Nixon R
Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders.
Annals of neurology 2001;50(5):661-5.
2001: Kinoshita A; Whelan C M; Smith C J; Mikhailenko I; Rebeck G W; Strickland D K; Hyman B T
Demonstration by fluorescence resonance energy transfer of two sites of interaction between the low-density lipoprotein receptor-related protein and the amyloid precursor protein: role of the intracellular adapter protein Fe65.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(21):8354-61.
2001: Deng A; Irizarry M C; Nitsch R M; Growdon J H; Rebeck G W
Elevation of cystatin C in susceptible neurons in Alzheimer's disease.
The American journal of pathology 2001;159(3):1061-8.
2001: Van Nostrand W E; Melchor J P; Cho H S; Greenberg S M; Rebeck G W
Pathogenic effects of D23N Iowa mutant amyloid beta -protein.
The Journal of biological chemistry 2001;276(35):32860-6.
2001: Berezovska O; Jack C; Deng A; Gastineau N; Rebeck G W; Hyman B T
Notch1 and amyloid precursor protein are competitive substrates for presenilin1-dependent gamma-secretase cleavage.
The Journal of biological chemistry 2001;276(32):30018-23.
2001: Rebeck G W; Cho H S; Grabowski T J; Greenberg S M
The effects of AbetaPP mutations and APOE polymorphisms on cerebral amyloid angiopathy.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2001;8 Suppl 1():43-7.
2001: Qiu Z; Naten D L; Liston J C; Yess J; Rebeck G W
A novel approach for studying endogenous abeta processing using cultured primary neurons isolated from APP transgenic mice.
Experimental neurology 2001;170(1):186-94.
2001: Grabowski T J; Cho H S; Vonsattel J P; Rebeck G W; Greenberg S M
Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy.
Annals of neurology 2001;49(6):697-705.
2001: Qiu Z; Strickland D K; Hyman B T; Rebeck G W
Elevation of LDL receptor-related protein levels via ligand interactions in Alzheimer disease and in vitro.
Journal of neuropathology and experimental neurology 2001;60(5):430-40.
2001: Cho H S; Hyman B T; Greenberg S M; Rebeck G W
Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.
Journal of neuropathology and experimental neurology 2001;60(4):342-9.
2001: Rebeck G W; Moir R D; Mui S; Strickland D K; Tanzi R E; Hyman B T
Association of membrane-bound amyloid precursor protein APP with the apolipoprotein E receptor LRP.
Brain research. Molecular brain research 2001;87(2):238-45.
2001: Bertram L; Guénette S; Jones J; Keeney D; Mullin K; Crystal A; Basu S; Yhu S; Deng A; Rebeck G W; Hyman B T; Go R; McInnis M; Blacker D; Tanzi R
No evidence for genetic association or linkage of the cathepsin D (CTSD) exon 2 polymorphism and Alzheimer disease.
Annals of neurology 2001;49(1):114-6.
2000: Guénette S Y; Bertram L; Crystal A; Bakondi B; Hyman B T; Rebeck G W; Tanzi R E; Blacker D
Evidence against association of the FE65 gene (APBB1) intron 13 polymorphism in Alzheimer's patients.
Neuroscience letters 2000;296(1):17-20.
2000: Finckh U; von der Kammer H; Velden J; Michel T; Andresen B; Deng A; Zhang J; Müller-Thomsen T; Zuchowski K; Menzer G; Mann U; Papassotiropoulos A; Heun R; Zurdel J; Holst F; Benussi L; Stoppe G; Reiss J; Miserez A R; Staehelin H B; Rebeck G W; Hyman B T; Binetti G; Hock C; Growdon J H; Nitsch R M
Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease.
Archives of neurology 2000;57(11):1579-83.
2000: Irizarry M C; Cheung B S; Rebeck G W; Paul S M; Bales K R; Hyman B T
Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice.
Acta neuropathologica 2000;100(5):451-8.
2000: Rebeck G W
Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease.
Neuroscience letters 2000;293(1):75-7.
2000: Bacskai B J; Xia M Q; Strickland D K; Rebeck G W; Hyman B T
The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(21):11551-6.
2000: Hyman B T; Strickland D; Rebeck G W
Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease.
Archives of neurology 2000;57(5):646-50.
2000: Greenberg S M; Cho H S; O'Donnell H C; Rosand J; Segal A Z; Younkin L H; Younkin S G; Rebeck G W
Plasma beta-amyloid peptide, transforming growth factor-beta 1, and risk for cerebral amyloid angiopathy.
Annals of the New York Academy of Sciences 2000;903():144-9.
2000: Ulery P G; Beers J; Mikhailenko I; Tanzi R E; Rebeck G W; Hyman B T; Strickland D K
Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease.
The Journal of biological chemistry 2000;275(10):7410-5.
2000: Irizarry M C; Rebeck G W; Cheung B; Bales K; Paul S M; Holzman D; Hyman B T
Modulation of A beta deposition in APP transgenic mice by an apolipoprotein E null background.
Annals of the New York Academy of Sciences 2000;920():171-8.
1999: Qiu Z; Strickland D K; Hyman B T; Rebeck G W
Alpha2-macroglobulin enhances the clearance of endogenous soluble beta-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons.
Journal of neurochemistry 1999;73(4):1393-8.
1999: Growdon W B; Cheung B S; Hyman B T; Rebeck G W
Lack of allelic imbalance in APOE epsilon3/4 brain mRNA expression in Alzheimer's disease.
Neuroscience letters 1999;272(2):83-6.
1999: Rebeck G W; Cheung B S; Growdon W B; Deng A; Akuthota P; Locascio J; Greenberg S M; Hyman B T
Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease.
Neuroscience letters 1999;272(3):155-8.
1999: Rebeck G W
Cutting in a lipid bilayer? Keystone Symposium on Molecular Mechanisms of Alzheimer Disease, Taos, New Mexico, USA, 3-8 March 1999.
Trends in genetics : TIG 1999;15(7):258-9.
1999: Lai F; Kammann E; Rebeck G W; Anderson A; Chen Y; Nixon R A
APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome.
Neurology 1999;53(2):331-6.
1999: Clatworthy A E; Stockinger W; Christie R H; Schneider W J; Nimpf J; Hyman B T; Rebeck G W
Expression and alternate splicing of apolipoprotein E receptor 2 in brain.
Neuroscience 1999;90(3):903-11.
1998: Liao A; Nitsch R M; Greenberg S M; Finckh U; Blacker D; Albert M; Rebeck G W; Gomez-Isla T; Clatworthy A; Binetti G; Hock C; Mueller-Thomsen T; Mann U; Zuchowski K; Beisiegel U; Staehelin H; Growdon J H; Tanzi R E; Hyman B T
Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease.
Human molecular genetics 1998;7(12):1953-6.
1998: Hollenbach E; Ackermann S; Hyman B T; Rebeck G W
Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease.
Neurology 1998;50(6):1905-7.
1998: Alonzo N C; Hyman B T; Rebeck G W; Greenberg S M
Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels.
Journal of neuropathology and experimental neurology 1998;57(4):353-9.
1998: Greenberg S M; Vonsattel J P; Segal A Z; Chiu R I; Clatworthy A E; Liao A; Hyman B T; Rebeck G W
Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy.
Neurology 1998;50(4):961-5.
1998: Rebeck G W; Alonzo N C; Berezovska O; Harr S D; Knowles R B; Growdon J H; Hyman B T; Mendez A J
Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes.
Experimental neurology 1998;149(1):175-82.
1997: Clatworthy A E; Gomez-Isla T; Rebeck G W; Wallace R B; Hyman B T
Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease.
Archives of neurology 1997;54(10):1289-92.
1996: Hyman B T; Gomez-Isla T; Rebeck G W; Briggs M; Chung H; West H L; Greenberg S; Mui S; Nichols S; Wallace R; Growdon J H
Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease.
Annals of the New York Academy of Sciences 1996;802():1-5.
1996: Mui S; Briggs M; Chung H; Wallace R B; Gomez-Isla T; Rebeck G W; Hyman B T
A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the epsilon 4 allele.
Neurology 1996;47(1):196-201.
1996: Chung H; Roberts C T; Greenberg S; Rebeck G W; Christie R; Wallace R; Jacob H J; Hyman B T
Lack of association of trinucleotide repeat polymorphisms in very-low-density lipoprotein receptor gene with Alzheimer's disease.
Annals of neurology 1996;39(6):800-3.
1996: Christie R H; Chung H; Rebeck G W; Strickland D; Hyman B T
Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease.
Journal of neuropathology and experimental neurology 1996;55(4):491-8.
1996: Hyman B T; Hedley-Whyte E T; Rebeck G W; Vonsattel J P; West H L; Growdon J H
Apolipoprotein E epsilon4/4 in a neuropathologically normal very elderly individual.
Archives of neurology 1996;53(3):215.
1996: Hyman B T; Gomez-Isla T; West H; Briggs M; Chung H; Growdon J H; Rebeck G W
Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology.
Annals of the New York Academy of Sciences 1996;777():158-65.
1996: Gomez-Isla T; West H L; Rebeck G W; Harr S D; Growdon J H; Locascio J J; Perls T T; Lipsitz L A; Hyman B T
Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
Annals of neurology 1996;39(1):62-70.
1995: Gearing M; Schneider J A; Rebeck G W; Hyman B T; Mirra S S
Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates.
Neurology 1995;45(11):1985-90.
1995: Mui S; Rebeck G W; McKenna-Yasek D; Hyman B T; Brown R H
Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis.
Annals of neurology 1995;38(3):460-3.
1995: Greenberg S M; Rebeck G W; Vonsattel J P; Gomez-Isla T; Hyman B T
Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy.
Annals of neurology 1995;38(2):254-9.
1995: Kounnas M Z; Moir R D; Rebeck G W; Bush A I; Argraves W S; Tanzi R E; Hyman B T; Strickland D K
LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation.
Cell 1995;82(2):331-40.
1995: Hyman B T; West H L; Rebeck G W; Buldyrev S V; Mantegna R N; Ukleja M; Havlin S; Stanley H E
Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).
Proceedings of the National Academy of Sciences of the United States of America 1995;92(8):3586-90.
1995: Nitsch R M; Rebeck G W; Deng M; Richardson U I; Tennis M; Schenk D B; Vigo-Pelfrey C; Lieberburg I; Wurtman R J; Hyman B T
Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype.
Annals of neurology 1995;37(4):512-8.
1995: Hyman B T; West H L; Rebeck G W; Lai F; Mann D M
Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.
Archives of neurology 1995;52(4):373-8.
1995: Rebeck G W; Hyman B T
Apolipoprotein E--correction.
Neurology 1995;45(3 Pt 1):598.
1995: Rebeck G W; Harr S D; Strickland D K; Hyman B T
Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein.
Annals of neurology 1995;37(2):211-7.
1994: Hyman B T; Strickland D K; Rebeck G W
Alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Relationship to apolipoprotein E and role in Alzheimer disease senile plaques.
Annals of the New York Academy of Sciences 1994;737():88-95.
1994: Gearing M; Rebeck G W; Hyman B T; Tigges J; Mirra S S
Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(20):9382-6.
1994: Rebeck G W; Perls T T; West H L; Sodhi P; Lipsitz L A; Hyman B T
Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals.
Neurology 1994;44(8):1513-6.
1994: West H L; Rebeck G W; Hyman B T
Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease.
Neuroscience letters 1994;175(1-2):46-8.
1994: Poduri A; Gearing M; Rebeck G W; Mirra S S; Tigges J; Hyman B T
Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys.
The American journal of pathology 1994;144(6):1183-7.
1994: Rebeck G W; Maynard K I; Hyman B T; Moskowitz M A
Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(9):3666-9.
1994: Simonian N A; Rebeck G W; Hyman B T
Functional integrity of neural systems related to memory in Alzheimer's disease.
Progress in brain research 1994;100():245-54.
1993: Rebeck G W; Reiter J S; Strickland D K; Hyman B T
Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions.
Neuron 1993;11(4):575-80.
1993: Rebeck G W; Marzloff K; Hyman B T
The pattern of NADPH-diaphorase staining, a marker of nitric oxide synthase activity, is altered in the perforant pathway terminal zone in Alzheimer's disease.
Neuroscience letters 1993;152(1-2):165-8.
1993: Rebeck G W; Hyman B T
Neuroanatomical connections and specific regional vulnerability in Alzheimer's disease.
Neurobiology of aging 1993;14(1):45-7; discussion 55-6.
1991: Rebeck G W; Samson L
Increased spontaneous mutation and alkylation sensitivity of Escherichia coli strains lacking the ogt O6-methylguanine DNA repair methyltransferase.
Journal of bacteriology 1991;173(6):2068-76.
1989: Rebeck G W; Smith C M; Goad D L; Samson L
Characterization of the major DNA repair methyltransferase activity in unadapted Escherichia coli and identification of a similar activity in Salmonella typhimurium.
Journal of bacteriology 1989;171(9):4563-8.
1988: Rebeck G W; Coons S; Carroll P; Samson L
A second DNA methyltransferase repair enzyme in Escherichia coli.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(9):3039-43.

Sign-in to see more